MOLN - Molecular Partners AG ADR logo

Molecular Partners AG ADR

MOLN

Molecular Partners AG develops designed ankyrin repeat protein therapeutics for oncology, focusing on treatments for solid tumors, acute myeloid leukemia, and ovarian cancer. Its pipeline includes various candidates in Phase 1 and Phase 2 trials.

โš•๏ธ Healthcare NASDAQ Listed 2021 CHF
$1,000 invested 5 years ago โ†’$206today

Score Overview

1 Year
Scoreโ€”
Net Growth6.66%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.0
Net Growth9.78%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score
Net Growth9.78%
Net Trend60%
Net Income Consistency
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Molecular Partners AG ADR has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. MOLN does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-29
$ 3.90โ€”
1 Year2025-09-29
$ 3.685.98%
5 Years2021-09-29
$ 18.96-79.43%
All Time2021-06-16
$ 19.65-80.15%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in CHF

Year
TTMCHF 0.00-CHF 57M
2025CHF 0.00-CHF 61MCHF 93M
2024CHF 4M-CHF 54MCHF 149M
2023CHF 7M-CHF 61MCHF 186M
2022CHF 189MCHF 117MCHF 249M
IPO2021CHF 9M-CHF 63MCHF 132M
MOLN - Molecular Partners AG ADR logo

Molecular Partners AG ADR fundamental performance

Between 2021 and 2025, revenue declined from CHF 9M to CHF 0.00 and net income went from -CHF 63M to -CHF 61M. Revenue increased in 20% of the years measured; net income in 60%.

Molecular Partners AG ADR currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.

Membership

Explore MOLN with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies